Not one round was won by scientists Alzheimer's disease. Most attempts to understand the mechanisms of the disease and to develop treatments were unsuccessful, writes Journal of Medicinal Chemistry. A recent study by researchers from South Korea was allowed to approach the understanding of pathology. As a result, scientists have offered their treatment for the disease.
A research group led by Dr. Pak Ki Dock of the brain Institute at the Korea Institute of science and technology and Professor of the medical faculty Ulsan University hwan He Gyu, engaged in the problems of Alzheimer's disease, notes that the new drug has a more pronounced positive effect than selegiline. This medicine has become a traditional appointment in Alzheimer's disease.
Experts draw attention to the fact that the side effects of new drugs significantly less. The main active component of the drug increases the concentration of proteins that slow down the destruction of nerve tissue, thereby increasing the life expectancy of the patient and his comfort.